(4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

C25H26N4O8 — CID 90954453

IUPAC(4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
SMILESCCc1cnc(Nc2ccc3c(c2O)C(=O)C2C(=O)[C@]4(O)C(=O)C(C(N)=O)C(=O)C[C@@H]4[C@@H](O)[C@@H]2[C@H]3C)[nH]1
InChIInChI=1S/C25H26N4O8/c1-3-9-7-27-24(28-9)29-12-5-4-10-8(2)14-17(20(33)15(10)19(12)32)22(35)25(37)11(18(14)31)6-13(30)16(21(25)34)23(26)36/h4-5,7-8,11,14,16-18,31-32,37H,3,6H2,1-2H3,(H2,26,36)(H2,27,28,29)/t8-,11+,14+,16?,17?,18+,25+/m0/s1
InChIKeyFSFNSMKJOSUXRT-RTUOUUCQSA-N
MW510.50 g/mol
LogP-0.11
Rot. Bonds4

About (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide

(4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide (PubChem CID 90954453) has the molecular formula C25H26N4O8 and a molecular weight of 510.50 g/mol. Its IUPAC name is (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide.

Molecular Properties

Compound Name(4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
PubChem CID90954453
Molecular FormulaC25H26N4O8
Molecular Weight510.50 g/mol
Exact Mass510.18
IUPAC Name(4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
SMILESCCc1cnc(Nc2ccc3c(c2O)C(=O)C2C(=O)[C@]4(O)C(=O)C(C(N)=O)C(=O)C[C@@H]4[C@@H](O)[C@@H]2[C@H]3C)[nH]1
InChIInChI=1S/C25H26N4O8/c1-3-9-7-27-24(28-9)29-12-5-4-10-8(2)14-17(20(33)15(10)19(12)32)22(35)25(37)11(18(14)31)6-13(30)16(21(25)34)23(26)36/h4-5,7-8,11,14,16-18,31-32,37H,3,6H2,1-2H3,(H2,26,36)(H2,27,28,29)/t8-,11+,14+,16?,17?,18+,25+/m0/s1
InChIKeyFSFNSMKJOSUXRT-RTUOUUCQSA-N
XLogP-0.11
TPSA212.77 Ų
H-Bond Donors6
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500510.50
LogP ≤ 5-0.11
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}

Analyze (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
The IUPAC name of (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide (CID 90954453) is (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide.
What is the SMILES notation for (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
The canonical SMILES for (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide is CCc1cnc(Nc2ccc3c(c2O)C(=O)C2C(=O)[C@]4(O)C(=O)C(C(N)=O)C(=O)C[C@@H]4[C@@H](O)[C@@H]2[C@H]3C)[nH]1.
What is the InChIKey of (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
The InChIKey is FSFNSMKJOSUXRT-RTUOUUCQSA-N. The full InChI is InChI=1S/C25H26N4O8/c1-3-9-7-27-24(28-9)29-12-5-4-10-8(2)14-17(20(33)15(10)19(12)32)22(35)25(37)11(18(14)31)6-13(30)16(21(25)34)23(26)36/h4-5,7-8,11,14,16-18,31-32,37H,3,6H2,1-2H3,(H2,26,36)(H2,27,28,29)/t8-,11+,14+,16?,17?,18+,25+/m0/s1.
What are the key properties of (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide?
(4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide has a molecular weight of 510.50 g/mol, XLogP of -0.11, 4 rotatable bonds, 6 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (4aR,5S,5aR,6R,12aS)-9-[(5-ethyl-1H-imidazol-2-yl)amino]-5,10,12a-trihydroxy-6-methyl-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide is sourced from PubChem (CID 90954453), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).